Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

@article{Kishi2013EfficacyAT,
  title={Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  author={T. Kishi and N. Iwata},
  journal={CNS Drugs},
  year={2013},
  volume={27},
  pages={731-741}
}
BackgroundPerospirone is a second-generation antipsychotic (SGA) used only in Japan, and acts as a serotonin (5-HT)1A receptor partial agonist, 5-HT2A receptor inverse agonist, and dopamine (D)2, D4, and α1-adrenergic receptor antagonist. To our knowledge, no meta-analysis addressing the efficacy and effectiveness of perospirone in schizophrenia has been published to date.ObjectiveThe aim of the study was to identify the characteristics of perospirone by assessing the efficacy, discontinuation… Expand
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
Management of Delirium in Palliative Care: a Review
Antipsychotics and the Dopamine–Serotonin Connection
Effects of Repetitive Transcranial Magnetic Stimulation Treatment on Event-Related Potentials in Schizophrenia
...
1
2
...

References

SHOWING 1-10 OF 21 REFERENCES
A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol
Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.
...
1
2
3
...